TransABseq: A Two-Stage Approach for Predicting Antigen-Antibody Binding Affinity Changes upon Mutation Based on

Cui-Feng Li1, Zihao Yan2, Fang Ge3

  • 1School of Computer, Jiangsu University of Science and Technology, 666 Changhui Road, Zhenjiang 212100, China.

The antigen-antibody interaction represents a critical mechanism in host defense, contributing to pathogen neutralization, tumor surveillance, immunotherapy, and in vitro disease detection. Owing to their exceptional specificity, affinity, and selectivity, antibodies have been extensively utilized in the development of clinical diagnostic, therapeutic, and prophylactic strategies. In this study, we propose TransABseq, a novel computational framework specifically designed to predict the effects of missense mutations on antigen-antibody interactions. The model's innovative two-stage architecture enables comprehensive feature analysis: in the first stage, multiple embeddings of protein language models are processed through a Transformer encoder module and a multiscale convolutional module; in the second stage, the XGBOOST model is used to perform quantitative output based on the deeply fused features. A critical advancement contributing to the effectiveness of TransABseq is the deep feature fusion strategy, which reveals the biochemical properties of proteins. By leveraging the multilayer self-attention mechanism of the Transformer to capture complex global dependencies within sequences and mining features at different hierarchical levels through multiscale convolution, the feature abstraction capability of TransABseq is significantly enhanced. We evaluated TransABseq through three distinct cross-validation strategies on two established benchmarks and a newly reconstructed data set. As a result, TransABseq achieved average PCC values of 0.607, 0.843, and 0.794 and average RMSE values of 1.166, 1.314, and 1.337 kcal/mol in 10-fold cross-validation. Furthermore, its robustness and predictive accuracy were validated on blind test data sets, where TransABseq outperformed existing methods, enabling it to attain a PCC of 0.721 and an RMSE of 0.925 kcal/mol. The relevant data and code have been made publicly available for academic research at: https://github.com/cuifengLI/TransABseq.

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
Mutations01:39

Mutations

Overview
77.4K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
84
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
10.6K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K